Guest guest Posted October 15, 2011 Report Share Posted October 15, 2011 News new results for Hepatitis IMS revises Incivek drug data; Vertex shares jump Reuters Incivek is one of two recently-launched hepatitis C drugs. It competes with Victrelis, made by Merck & Co . Both drugs promise a higher cure rate for the disease, which infects the liver and can lead eventually to cirrhosis and liver failure. ... See all stories on this topic »Anadys achieves positive interim results in ongoing phase 2b hepatitis C study Proactive Investors USA & Canada Anadys Pharmaceuticals (NASDAQ:ANDS) announced Thursday positive interim results in its ongoing phase 2b study of setrobuvir, in combination with pegylated interferon and ribavirin (P/R), in patients with the hepatitis C virus. ... See all stories on this topic » Hepatitis warning to Japanese diners ABC Online A public health warning has been issued after a staff member of a Japanese restaurant in Adelaide was diagnosed with hepatitis A. People who ate at the Yakitori Takumi restaurant in Melbourne Street at North Adelaide between September 21 and October 4 ... See all stories on this topic »Worker at popular Yakatori Takumi restaurant contracts Hepatitis A NEWS.com.au A FOOD handler at a North Adelaide restaurant has contracted Hepatitis A, forcing SA Health to issue a public health alert. Chief Medical Officer Professor Paddy said the food handler worked at Yakatori Takumi restaurant on Melbourne St and ... See all stories on this topic »Achillion Announces Nomination of Second Generation NS5A Inhibitor for the ... MarketWatch (press release) " Inhibition of the NS5A target is one of the most compelling approaches to treating hepatitis C. With the development of this second generation compound, ACH-3102, with its improved antiviral activity and potency, we continue to deliver on our ... See all stories on this topic »Hepatitis C Medication Adherence Is an Important Challenge, Study Shows AIDSmeds.com HIV/AIDS Treatment News Identifying and overcoming barriers to hepatitis C medication adherence is an essential component to treatment strategies, according to study results published online by ls of Internal Medicine. Patients being treated for chronic hepatitis C become ... See all stories on this topic »UC San Diego School of Medicine Launches Hepatitis C Clinical Trials UCSD Medical Center A collaborative partnership between the UC San Diego Liver Center and Antiviral Research Center (AVRC) has resulted in 19 clinical trials for hepatitis C virus (HCV), focused on developing more effective and well-tolerated HCV treatments. .... See all stories on this topic »Hepatitis C verdict misplaces blame Las Vegas Sun What a shame that the jurors in the recent hepatitis C outbreak case awarded $162.5 million in punitive damages to the three people infected. The actions of today's jurors to hand out ridiculous amounts in these cases does nothing but drive up the ... See all stories on this topic »Inovio, VGX ink hep B and C vaccine deal FierceVaccines Blue Bell, PA-based Inovio Pharmaceuticals and VGX International will collaborate on the development of Inovio's synthetic vaccines for hepatitis B and hepatitis C. Financial details of the deal were not disclosed. Inovio's SynCon vaccine technology ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.